Clinical Trial Update: Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment [Phase 3]

View source ↗

Summary

A Phase 3 trial is assessing whether oral colchicine can prevent proliferative vitreoretinopathy following rhegmatogenous retinal detachment, with results not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhegmatogenous Retinal Detachment

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Rhegmatogenous Retinal Detachment | Phase 3 | Status: UNKNOWN